|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.82 USD | -1.62% |
|
+1.68% | -4.21% |
| 04-18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
| 04-15 | I-Mab Announces Chief Medical Officer Changes | CI |
I-Mab reported earnings results for the half year ended June 30, 2023. For the half year, the company reported revenue was CNY 19.66 million compared to CNY 51.86 million a year ago. Net loss was CNY 772.8 million compared to CNY 1,046.86 million a year ago.
Basic loss per share from continuing operations was CNY 9.292 compared to CNY 12.742 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.21% | 149M | |
| +31.37% | 588B | |
| -2.60% | 364B | |
| +20.83% | 326B | |
| +5.69% | 285B | |
| +14.83% | 239B | |
| +9.93% | 210B | |
| -6.95% | 200B | |
| +10.77% | 167B | |
| +0.10% | 161B |
I-MAB 
